113 related articles for article (PubMed ID: 6320314)
1. Evidence that proglumide and benzotript antagonize secretagogue stimulation of isolated gastric parietal cells.
Magous R; Bali JP
Regul Pept; 1983 Nov; 7(3):233-41. PubMed ID: 6320314
[TBL] [Abstract][Full Text] [Related]
2. Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists.
Hahne WF; Jensen RT; Lemp GF; Gardner JD
Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6304-8. PubMed ID: 6171817
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide.
Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR
Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines.
Hoosein NM; Kiener PA; Curry RC; Rovati LC; McGilbra DK; Brattain MG
Cancer Res; 1988 Dec; 48(24 Pt 1):7179-83. PubMed ID: 3191491
[TBL] [Abstract][Full Text] [Related]
5. Affinity of cholecystokinin receptor antagonists for the gastrin-binding protein.
Rorison KA; Yang Z; Baldwin GS
Eur J Pharmacol; 2000 Jan; 388(1):9-15. PubMed ID: 10657541
[TBL] [Abstract][Full Text] [Related]
6. Gastrin receptors on isolated canine parietal cells.
Soll AH; Amirian DA; Thomas LP; Reedy TJ; Elashoff JD
J Clin Invest; 1984 May; 73(5):1434-47. PubMed ID: 6325503
[TBL] [Abstract][Full Text] [Related]
7. Proglumide inhibition of trophic action of pentagastrin.
Johnson LR; Guthrie PD
Am J Physiol; 1984 Jan; 246(1 Pt 1):G62-6. PubMed ID: 6320664
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a gastrin-type receptor on rabbit gastric parietal cells using L365,260 and L364,718.
Roche S; Bali JP; Galleyrand JC; Magous R
Am J Physiol; 1991 Feb; 260(2 Pt 1):G182-8. PubMed ID: 1996638
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of pancreatic growth induced by pancreatico-biliary diversion in the rat. Inhibition by proglumide, benzotript, and ranitidine.
Miazza BM; Turberg Y; Guillaume P; Hahne W; Chayvialle JA; Loizeau E
Scand J Gastroenterol Suppl; 1985; 112():75-83. PubMed ID: 2409583
[TBL] [Abstract][Full Text] [Related]
10. High-affinity binding sites for gastrin on isolated rabbit gastric mucosal cells.
Magous R; Bali JP
Eur J Pharmacol; 1982 Aug; 82(1-2):47-54. PubMed ID: 6290232
[TBL] [Abstract][Full Text] [Related]
11. Gastrin and gastrin receptor antagonists bind to both N- and C-terminal halves of the 78 kDa gastrin-binding protein.
Murphy VJ; Mantamadiotis T; Baldwin GS
Int J Biochem Cell Biol; 1996 Nov; 28(11):1233-40. PubMed ID: 9022282
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of pentagastrin-stimulated up-regulation of gastrin receptors and growth of mouse colon tumor in vivo by proglumide, a gastrin receptor antagonist.
Singh P; Le S; Beauchamp RD; Townsend CM; Thompson JC
Cancer Res; 1987 Oct; 47(19):5000-4. PubMed ID: 3621187
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans.
Schmidt WE; Schenk S; Nustede R; Holst JJ; Fölsch UR; Creutzfeldt W
Gastroenterology; 1994 Dec; 107(6):1610-20. PubMed ID: 7958670
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the preferential binding of actin to the N-terminal hydratase domain of the 78-kDa gastrin-binding protein by non-steroidal anti-inflammatory drugs and gastrin receptor antagonists.
Baldwin GS
Biochem Pharmacol; 2001 May; 61(9):1129-36. PubMed ID: 11301046
[TBL] [Abstract][Full Text] [Related]
15. Effects of proglumide on pancreatic acinar cell function.
Williams JA; Bailey A; Steigerwalt RW
Digestion; 1983; 27(4):227-33. PubMed ID: 6197332
[TBL] [Abstract][Full Text] [Related]
16. Proglumide (gastrin and cholecystokinin receptor antagonist) inhibits insulin secretion in vitro.
Verspohl EJ; Wunderle G; Ammon HP; Williams JA; Goldfine ID
Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):284-7. PubMed ID: 3012373
[TBL] [Abstract][Full Text] [Related]
17. Are C-terminal octapeptide of cholecystokinin and [Leu11]gastrin-(5-17) different in stimulating acid secretion in isolated rabbit gastric glands?
Oiry C; Galleyrand JC; Lima-Leite AC; Fulcrand P; Martinez J
Eur J Pharmacol; 1995 Dec; 294(2-3):511-9. PubMed ID: 8750713
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of gastrin-stimulated growth of gastrointestinal tumour cells by octreotide and the gastrin/cholecystokinin receptor antagonists, proglumide and lorglumide.
Watson SA; Morris DL; Durrant LG; Robertson JF; Hardcastle JD
Eur J Cancer; 1992; 28A(8-9):1462-7. PubMed ID: 1355350
[TBL] [Abstract][Full Text] [Related]
19. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
Crawley JN; Stivers JA; Hommer DW; Skirboll LR; Paul SM
J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
[TBL] [Abstract][Full Text] [Related]
20. Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin.
Niederau C; Ferrell LD; Grendell JH
Gastroenterology; 1985 May; 88(5 Pt 1):1192-204. PubMed ID: 2984080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
